Posaconazole
Showing 26 - 50 of 105
Neutropenia Trial (Posaconazole IV solution, Posaconazole powder for oral suspension)
Completed
- Neutropenia
- Posaconazole IV solution
- Posaconazole powder for oral suspension
- (no location specified)
May 28, 2019
Myelodysplastic Syndrome Patients
Completed
- Myelodysplastic Syndrome
- Antibiotic and antifungal drugs
-
Alessandria, Italy
- +24 more
Sep 6, 2021
Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +8 more
- DS-1594b
- +14 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain Trial in Hershey (Ketoconazole)
Recruiting
- Glioblastoma
- +3 more
-
Hershey, PennsylvaniaPenn State Milton S Hershey Medical Center
Jul 12, 2022
Azole Resistance in A. Fumigatus to Improve Patient Outcome.
Completed
- Aspergillosis, Invasive Pulmonary
- PCR based detection of azole resistance in A. fumigatus
-
Amsterdam, Netherlands
- +7 more
Mar 22, 2022
Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte
Recruiting
- Acute Myeloid Leukemia
- Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- "3+7"
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 29, 2023
Leukemia, Fungal Infection Trial in Houston (Posaconazole)
Completed
- Leukemia
- Fungal Infection
- Posaconazole
-
Houston, TexasUT MD Anderson Cancer Center
Feb 5, 2019
Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
Completed
- Relapsed Acute Myeloid Leukemia
- +3 more
- VAH regimen
- VEN+HMA regimen
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 8, 2022
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives
Recruiting
- Critical Illness
- +2 more
- blood drug concentration
-
Harefield, Middlesex, United KingdomRoyal Brompton & Harefield NHS Foundation Trust
Dec 17, 2020
Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)
Recruiting
- Hypomethylating Agent
- +2 more
- Venetoclax
- Azacitidine or decitabine
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023
Pharmacokinetics Trial in Dallas (Milademetan, Itraconazole, Posaconazole)
Completed
- Pharmacokinetics
- Milademetan
- +2 more
-
Dallas, TexasCovance Clinical Research Unit, Inc.
Feb 8, 2019
Invasive Fungal Infections Trial in Italy
Completed
- Invasive Fungal Infections
-
Bologna, Italy
- +13 more
Oct 25, 2022
Venetoclax Plasma Concentration and Remission in Acute Myeloid
Not yet recruiting
- Adult Acute Myeloid Leukemia
- Blood sampling for venetoclax drug dosage (venous puncture)
- (no location specified)
Sep 13, 2023
Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)
Recruiting
- Previously Untreated Acute Myeloid Leukemia
- Samalizumab (BAML-16-001-S1)
- +32 more
-
Phoenix, Arizona
- +18 more
Oct 17, 2022
Respiratory Syncytial Virus Infections Trial in Worldwide (JNJ-53718678 250 mg, Placebo, JNJ-53718678 125 mg)
Terminated
- Respiratory Syncytial Virus Infections
- JNJ-53718678 250 mg
- +2 more
-
Los Angeles, California
- +68 more
Mar 3, 2022
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
CMV Viremia Trial (Letermovir Pill)
Not yet recruiting
- CMV Viremia
- Letermovir Pill
- (no location specified)
Jun 20, 2022
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)
Recruiting
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Houston, Texas
- +5 more
May 31, 2022
Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2022
Febrile Neutropenia Trial (Early Discontinuation of Antibiotics, Standard of Care)
Not yet recruiting
- Febrile Neutropenia
- Early Discontinuation of Antibiotics
- Standard of Care
- (no location specified)
Mar 24, 2023
Febrile Neutropenia Trial in Winston-Salem (Meropenem, Micafungin)
Not yet recruiting
- Febrile Neutropenia
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Mar 13, 2023
Invasive Fungal Infections in Patients Following Stem Cell
Unknown status
- Invasive Fungal Infections
- Stem Cell Transplant Complications
- No intervention
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Nov 4, 2020